Comments
Loading...

Cellebrite DI

CLBTNASDAQ
Logo brought to you by Benzinga Data
$22.52
1.235.78%
At close: -
$22.70
0.180.80%
After Hours: Dec 20, 7:51 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$24.00
Lowest Price Target1
$10.00
Consensus Price Target1
$17.60

Cellebrite DI (NASDAQ:CLBT) Stock, Analyst Ratings, Price Targets, Forecasts

Cellebrite DI Ltd has a consensus price target of $17.6 based on the ratings of 11 analysts. The high is $24 issued by JP Morgan on December 16, 2024. The low is $10 issued by JP Morgan on August 9, 2023. The 3 most-recent analyst ratings were released by JP Morgan, Craig-Hallum, and JP Morgan on December 16, 2024, November 7, 2024, and November 7, 2024, respectively. With an average price target of $23.33 between JP Morgan, Craig-Hallum, and JP Morgan, there's an implied 2.79% upside for Cellebrite DI Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
7
Aug
2
Sep
3
Nov
1
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
Craig-Hallum
Needham
TD Cowen
Deutsche Bank

1calculated from analyst ratings

Analyst Ratings for Cellebrite DI

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cellebrite DI (CLBT) stock?

A

The latest price target for Cellebrite DI (NASDAQ:CLBT) was reported by JP Morgan on December 16, 2024. The analyst firm set a price target for $24.00 expecting CLBT to rise to within 12 months (a possible 5.73% upside). 22 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cellebrite DI (CLBT)?

A

The latest analyst rating for Cellebrite DI (NASDAQ:CLBT) was provided by JP Morgan, and Cellebrite DI maintained their overweight rating.

Q

When was the last upgrade for Cellebrite DI (CLBT)?

A

The last upgrade for Cellebrite DI Ltd happened on March 13, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Cellebrite DI Ltd.

Q

When was the last downgrade for Cellebrite DI (CLBT)?

A

The last downgrade for Cellebrite DI Ltd happened on August 12, 2022 when B of A Securities changed their price target from $6.5 to $6 for Cellebrite DI Ltd.

Q

When is the next analyst rating going to be posted or updated for Cellebrite DI (CLBT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellebrite DI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellebrite DI was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

Q

Is the Analyst Rating Cellebrite DI (CLBT) correct?

A

While ratings are subjective and will change, the latest Cellebrite DI (CLBT) rating was a maintained with a price target of $22.00 to $24.00. The current price Cellebrite DI (CLBT) is trading at is $22.70, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.